These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25460500)

  • 61. DNA methylation-related vitamin D receptor insensitivity in breast cancer.
    Marik R; Fackler M; Gabrielson E; Zeiger MA; Sukumar S; Stearns V; Umbricht CB
    Cancer Biol Ther; 2010 Jul; 10(1):44-53. PubMed ID: 20431345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
    Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
    Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.
    Somasundaram K; Zhang H; Zeng YX; Houvras Y; Peng Y; Zhang H; Wu GS; Licht JD; Weber BL; El-Deiry WS
    Nature; 1997 Sep; 389(6647):187-90. PubMed ID: 9296497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cellular expression levels of the vitamin D receptor are critical to its transcriptional regulation by the pituitary transcription factor Pit-1.
    Seoane S; Ben I; Centeno V; Perez-Fernandez R
    Mol Endocrinol; 2007 Jul; 21(7):1513-25. PubMed ID: 17456792
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BRCA1 represses amphiregulin gene expression.
    Lamber EP; Horwitz AA; Parvin JD
    Cancer Res; 2010 Feb; 70(3):996-1005. PubMed ID: 20103632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Resistance of HBL100 human breast epithelial cells to vitamin D action.
    Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
    Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
    [TBL] [Abstract][Full Text] [Related]  

  • 68. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
    Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
    J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
    [TBL] [Abstract][Full Text] [Related]  

  • 69. QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells.
    Sundaram S; Beckman MJ; Bajwa A; Wei J; Smith KM; Posner GH; Gewirtz DA
    Mol Cancer Ther; 2006 Nov; 5(11):2806-14. PubMed ID: 17121927
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
    Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
    Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.
    Malloy PJ; Peng L; Wang J; Feldman D
    Endocrinology; 2009 Apr; 150(4):1580-7. PubMed ID: 19056816
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients.
    Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M
    Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Switches in histone modifications epigenetically control vitamin D3-dependent transcriptional upregulation of the CYP24A1 gene in osteoblastic cells.
    Moena D; Merino P; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2020 Jun; 235(6):5328-5339. PubMed ID: 31868234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. BRCA1 regulates the cancer stem cell fate of breast cancer cells in the context of hypoxia and histone deacetylase inhibitors.
    Kim H; Lin Q; Yun Z
    Sci Rep; 2019 Jul; 9(1):9702. PubMed ID: 31273285
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.
    Lopes N; Carvalho J; Durães C; Sousa B; Gomes M; Costa JL; Oliveira C; Paredes J; Schmitt F
    Anticancer Res; 2012 Jan; 32(1):249-57. PubMed ID: 22213313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
    Quack M; Carlberg C
    Mol Pharmacol; 1999 Jun; 55(6):1077-87. PubMed ID: 10347251
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
    Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.